Personalized genomic medicine: Lessons from the exome

Molecular Genetics and Metabolism

Volumn 104, Issue 1-2, 2011, Pages 189-191

  Solomon, Benjamin D ^a   Pineda Alvarez, Daniel E ^a   Hadley, Donald W ^a   Teer, Jamie K ^a   Cherukuri, Praveen F ^a   Hansen, Nancy F ^a   Cruz, Pedro ^a   Young, Alice C ^a   Blakesley, Robert W ^a   Lanpher, Brendan ^b   Mayfield Gibson, Stephanie ^c   Sincan, Murat ^d   Chandrasekharappa, Settara C ^a   Mullikin, James C ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c Kentucky Department for Public Health   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CPSI; Pulmonary artery hypertension; VACTERL; Whole exome sequencing

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; DOPAMINE; HYDROCORTISONE; MILRINONE; NITRIC OXIDE; SILDENAFIL;

ARTICLE; CASE REPORT; CHILD; ECHOCARDIOGRAPHY; ENVIRONMENTAL FACTOR; EXOME; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOME; HETEROZYGOTE; HUMAN; MONOZYGOTIC TWINS; NEWBORN SCREENING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE EXOME SEQUENCING;

EID: 80052521660     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.06.022     Document Type: Article

References (17)

1. Ng S.B., Buckingham K.J., Lee C., Bigham A.W., Tabor H.K., Dent K.M., Huff C.D., Shannon P.T., Jabs E.W., Nickerson D.A., Shendure J., Bamshad M.J. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42:30-35.
2. Teer J.K., Mullikin J.C. Exome sequencing: the sweet spot before whole genomes. Hum. Mol. Genet. 2010, 19:R145-151.
3. Tucker T., Marra M., Friedman J.M. Massively parallel sequencing: the next big thing in genetic medicine. Am. J. Hum. Genet. 2009, 85:142-154.
4. Quan L., Smith D.W. The VATER association. Vertebral defects, Anal atresia, T-E fistula with esophageal atresia, Radial and Renal dysplasia: a spectrum of associated defects. J. Pediatr. 1973, 82:104-107.
5. Solomon B.D., Pineda-Alvarez D.E., Raam M.S., Bous S.M., Keaton A.A., Velez J.I., Cummings D.A. Analysis of component findings in 79 patients diagnosed with VACTERL association. Am. J. Med. Genet. A 2010, 152A:2236-2244.
6. Holland A.J., Fitzgerald D.A. Oesophageal atresia and tracheo-oesophageal fistula: current management strategies and complications. Paediatr. Respir. Rev. 2010, 11:100-106. (quiz 106-107).
7. Spitz L. Oesophageal atresia. Orphanet J. Rare Dis. 2007, 2:24.
8. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
9. Haberle J., Shchelochkov O.A., Wang J., Katsonis P., Hall L., Reiss S., Eeds A., Willis A., Yadav M., Summar S., Lichtarge O., Rubio V., Wong L.J., Summar M. Molecular defects in human carbamoyl phosphate synthetase i: mutational spectrum, diagnostic and protein structure considerations. Hum. Mutat. 2011, 32:579-589.
10. Pearson D.L., Dawling S., Walsh W.F., Haines J.L., Christman B.W., Bazyk A., Scott N., Summar M.L. Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N. Engl. J. Med. 2001, 344:1832-1838.
11. Summar M.L., Gainer J.V., Pretorius M., Malave H., Harris S., Hall L.D., Weisberg A., Vaughan D.E., Christman B.W., Brown N.J. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function. Hypertension 2004, 43:186-191.
12. Canter J.A., Summar M.L., Smith H.B., Rice G.D., Hall L.D., Ritchie M.D., Motsinger A.A., Christian K.G., Drinkwater D.C., Scholl F.G., Dyer K.L., Kavanaugh-McHugh A.L., Barr F.E. Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study. Mitochondrion 2007, 7:204-210.
13. Hoshide R., Matsuura T., Haraguchi Y., Endo F., Yoshinaga M., Matsuda I. Carbamyl phosphate synthetase I deficiency. One base substitution in an exon of the CPS I gene causes a 9-basepair deletion due to aberrant splicing. J. Clin. Invest. 1993, 91:1884-1887.
14. Barr F.E., Beverley H., VanHook K., Cermak E., Christian K., Drinkwater D., Dyer K., Raggio N.T., Moore J.H., Christman B., Summar M. Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. J. Pediatr. 2003, 142:26-30.
15. Smith H.A., Canter J.A., Christian K.G., Drinkwater D.C., Scholl F.G., Christman B.W., Rice G.D., Barr F.E., Summar M.L. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J. Thorac. Cardiovasc. Surg. 2006, 132:58-65.
16. Badesch D.B., Abman S.H., Ahearn G.S., Barst R.J., McCrory D.C., Simonneau G., McLaughlin V.V. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004, 126:35S-62S.
17. Schulze-Neick I., Penny D.J., Rigby M.L., Morgan C., Kelleher A., Collins P., Li J., Bush A., Shinebourne E.A., Redington A.N. L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery. Circulation 1999, 100:749-755.